Coronavirus: Switzerland gives OK to Pfizer/Biontech COVID-19 vaccine

Published: Updated:
Enable Read mode
100% Font Size

Swiss drugs regulator Swissmedic has authorised the COVID-19 vaccine from Pfizer and partner BioNTech, the agency said on Saturday.

“According to the data assessed by the Swiss Agency for Therapeutic Products, the level of protection afforded seven days after the second injection of the vaccine is over 90 percent. This represents the world’s first authorization in the ordinary procedure,” Swissmedic said on its website.

For more coronavirus news, visit our dedicated page.

Top Content Trending